Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Oct;26(5):280-90.
doi: 10.1017/neu.2014.9.

Protocol to evaluate the impact of yoga supplementation on cognitive function in schizophrenia: a randomised controlled trial

Triptish Bhatia  1 , Sati Mazumdar  2 , Nagendra Narayan Mishra  1 , Raquel E Gur  3 , Ruben C Gur  3 , Vishwajit Laxmikant Nimgaonkar  4 , Smita Neelkanth Deshpande  1
Affiliations
Randomized Controlled Trial

Protocol to evaluate the impact of yoga supplementation on cognitive function in schizophrenia: a randomised controlled trial

Triptish Bhatia et al. Acta Neuropsychiatr. 2014 Oct.

Abstract

Background: Schizophrenia (SZ) is a chronic illness that is treated symptomatically. Cognitive dysfunction is a core feature of SZ that is relatively intractable to pharmacotherapy. Yoga can improve cognitive function among healthy individuals. A recent open trial indicated significant benefits of yoga training (YT) in conjunction with conventional pharmacotherapy among patients with SZ.

Aims: To describe the protocol for an ongoing randomised controlled trial designed to test whether the reported beneficial effects of YT on cognitive function among SZ patients can be replicated. Secondarily, the effects of YT on daily functioning living skills are evaluated.

Methods: Consenting patients with SZ receive routine clinical treatment and are randomised to adjunctive YT, adjunctive physical exercise (PE) or treatment as usual (proposed N = 234 total, N = 78 in each group). The trial involves YT or PE 5 days a week and lasts 3 weeks. Participants are evaluated thrice over 6 months. Cognitive functions measured by Trail Making Test, University of Pennsylvania Neurocognitive Computerised Battery were primary outcome measures while clinical severity and daily functioning measured by Independent Living Skills Survey were secondary outcome measures.

Results: A total of 309 participants have been randomised as of 31 August 2013, which exceeded beyond 294 proposed after attrition. Once participants begin YT or PE they generally complete the protocol. No injuries have been reported.

Conclusions: Short term YT is feasible and acceptable to Indian SZ patients. If beneficial effects of YT are detected, it will provide a novel adjunctive cognitive remediation strategy for SZ patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow Chart of Enrollment till August 31, 2013.
See this image and copyright information in PMC

References

    1. KITCHEN H, ROFAIL D, HERON L, SACCO P. Cognitive impairment associated with schizophrenia: a review of the humanistic burden. Adv Ther. 2012;29:148–162. - PubMed
    1. HEINRICHS RW, ZAKZANIS KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426–445. - PubMed
    1. GOLDBERG T, GREEN M. Neurocognitive functioning inpatients with schizophrenia: an overview. Lippincott: Williams & Wilkins; Philadelphia, PA: 2002.
    1. NUECHTERLEIN KH, BARCH DM, GOLD JM, GOLDBERG TE, GREEN MF, HEATON RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72:29–39. - PubMed
    1. KEEFE RS, HARVEY PD. Cognitive impairment in schizophrenia. Handb Exp Pharmacol. 2012;213:11–37. - PubMed

Publication types